| 000 | 01322 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515133139.0 | ||
| 264 | 0 | _c20080904 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a1537-1948 | ||
| 024 | 7 |
_a10.1097/MLR.0b013e3181858edc _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKatz, Mitchell H | |
| 245 | 0 | 0 |
_aDecreasing use of controlled-release oxycodone: response to Morden et al, June 2008 Medical Care. _h[electronic resource] |
| 260 |
_bMedical care _cSep 2008 |
||
| 300 |
_a1002 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadverse effects |
| 650 | 0 | 4 | _aCalifornia |
| 650 | 0 | 4 | _aCost Savings |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 |
_aDrug Costs _xstatistics & numerical data |
| 650 | 0 | 4 |
_aDrug Utilization _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug and Narcotic Control _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedicaid _xeconomics |
| 650 | 0 | 4 |
_aOxycodone _xadverse effects |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 |
_aSubstance-Related Disorders _xprevention & control |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aKotabe, Sharon | |
| 773 | 0 |
_tMedical care _gvol. 46 _gno. 9 _gp. 1002 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MLR.0b013e3181858edc _zAvailable from publisher's website |
| 999 |
_c18197271 _d18197271 |
||